In schizophrenia with diabetes, a GLP-1 drug was linked to fewer psychiatric admissions
A US records study of 70 257 adults with schizophrenia and type 2 diabetes, published in November 2026 in The Lancet Psychiatry, linked starting a GLP-1 drug to fewer psychiatric hospitalizations than…